Myocardial blood flow and myocardial flow reserve values in 13 N–ammonia myocardial perfusion PET/CT using a time-efficient protocol in patients without coronary artery disease

Opstal TSJ; Knol RJJ; Cornel JH; Wondergem M; van der Zant FM

doi:10.1186/s41824-018-0029-z

Original article

Open Access

Myocardial blood flow and myocardial flow reserve values in ¹³N–ammonia myocardial perfusion PET/CT using a time-efficient protocol in patients without coronary artery disease

Opstal TSJ^{1, 3}Email author,
Knol RJJ^{1, 2},
Cornel JH^{2, 3},
Wondergem M^{1, 2} and
van der Zant FM^{1, 2}

European Journal of Hybrid ImagingEJNMMI Multimodality Journal20182:11

https://doi.org/10.1186/s41824-018-0029-z

Received: 8 November 2017

Accepted: 19 February 2018

Published: 11 June 2018

Abstract

Background

Cardiac imaging by means of myocardial Positron Emission Tomography/Computed Tomography (PET/CT) is being used increasingly to assess coronary artery disease, to guide revascularization decisions with more accuracy, and it allows robust quantitative analysis of both regional myocardial blood flow (MBF) and myocardial flow reserve (MFR).

Recently, a more time-efficient protocol has been developed in combination with a residual activity correction algorithm in which a stress acquisition is performed directly after completion of the rest acquisition to subtract remaining myocardial radioactivity.

The objective of this study is to define flow values of myocardial blood flow (MBF) and Myocardial Flow Reserve (MFR) with ¹³N–ammonia (¹³NH₃) myocardial perfusion PET/CT on patients without coronary artery disease using a time-efficient protocol, since reference values for this particular type of study are lacking in literature. In addition, we aim to determine the effect of the residual activity correction algorithm in this time-efficient protocol.

Results

A mean MBF in rest of 1.02 ± 0.22 ml/g/min, a mean MBF in stress of 2.54 ± 0.41 ml/g/min with a mean MFR of 2.60 ± 0.61 were measured. Female patients had a significant higher MBF in rest and stress, but lower MFR; a small but significant negative correlation was measured between age and MBF in stress and MFR. Residual activity correction had a significant effect resulting in a difference in global stress MBF before and after correction of 0.39 ± 0.13 ml/g/min.

Conclusions

This study established flow values for ¹³NH₃ myocardial PET/CT with a time-efficient protocol, and established that MBF in stress corrected for residual activity is comparable with known reference values in normal studies without temporal overlap. Further validation of the technique could be of value, e.g. by comparison to standard imaging without temporal overlap, or validation against catheterization results.

Keywords

Myocardial PET/CT13 N–ammoniaStress flowFlow reserveResidual activity correctionTime-efficient protocol

Background

Cardiac imaging by means of myocardial Positron Emission Tomography/Computed Tomography (PET/CT) is being used increasingly to assess coronary artery disease (CAD) and to guide revascularization decisions with more accuracy. Against conventional myocardial perfusion scintigraphy, this modality appears to be cost-effective, of comparable diagnostic performance and has strong prognostic power (Dorbala and Di Carli 2014; Juneau et al. 2016; Merhige et al. 2007). In addition, myocardial perfusion PET/CT allows robust quantitative analysis of both regional myocardial blood flow (MBF) during rest and pharmacologically induced stress and myocardial flow reserve (MFR) (Gould et al. 2013).

Nitrogen-13 ammonia (¹³NH₃) is a common tracer used for myocardial perfusion PET/CTs with a half-live of 9.96 min (Anagnostopoulos et al. 2013). This half-live results in an obligatory time-consuming pause of 30 to 60 min (Juarez-Orozco et al. 2016; Kawaguchi et al. 2017) and subsequent repositioning of the patient between rest and stress scans, to avoid overlap of remaining, yet undecayed, myocardial radioactivity of the rest scan. Recently, a more time-efficient protocol has been developed in which a stress acquisition is performed directly after completion of the rest acquisition. This protocol is implemented in combination with a residual activity correction algorithm embedded in Syngo MBF software package (Siemens Healthcare, Knoxville, Tennessee, USA) to subtract remaining myocardial radioactivity.

The objective of the present study is to determine flow values of MBF and MFR in ¹³NH₃ myocardial perfusion PET/CTs of a regular outpatient population to which a time-efficient protocol with a residual activity correction algorithm was applied, since reference values for this particular type of study are lacking in literature. In this report, we summarize data of a cohort study in patients without any signs of CAD on PET/CT or during follow-up. In addition, we aim to determine the effect of the residual activity correction algorithm on stress MBF in this time-efficient protocol.

Methods

Patient selection

In this cohort study all patients that were referred to ¹³NH₃ myocardial PET/CT were prospectively recorded in a database from December 2013 until November 2016. All patients gave written informed consent for the use of their data for scientific purposes. Besides our standard time-efficient imaging protocol and clinical management no additional measurements or actions affecting the patient were performed. Therefore, approval of the local ethical committee for the present study was not necessary since the study does not fall within the scope of the Dutch Medical Research Involving Human Subjects Act (section 1.b WMO, 26th February 1998).

Patients with a clinical history of CAD or signs of CAD on previous imaging studies were excluded. Patients with abnormal ¹³NH₃ myocardial PET/CT results in terms of visual ischemia or infarction were also excluded, as were patients who showed coronary calcifications on the attenuation correction CT of the myocardial perfusion PET/CT. Patients with incomplete or visually suboptimal PET/CTs (e.g. due to motion artefacts) were also excluded. Patients displaying stress MBF below 1.8 ml/gm/min were excluded, since this somewhat arbitrary threshold value is considered below expected lower limits in previous literature (Gould et al. 2013; Hutchins et al. 1990) and could be caused by coronary microvascular disease.

The remaining patients were followed up after the ¹³NH₃ PET/CT study until December 2016 by a thorough screening of the electronic medical records of each patient. In these records all emergency room presentations, hospital admissions, cardiac events, and cardiac and non-cardiac procedures in our hospital were recorded. Any events occurring in other hospitals are most likely recorded by our cardiologists during follow-up as outpatient. Patients were excluded if, according to these records, they suffered a major adverse cardiovascular event (MACE), defined as sudden cardiac death, non-fatal out of hospital cardiac arrest, acute coronary syndrome or atherosclerotic ischemic stroke.

Image acquisition and reconstruction parameters

All image data were acquired in list mode on a Siemens Biograph-16 TruePoint PET/CT (Siemens Healthcare, Knoxville, Tennessee, USA) with the TrueV option (enabled the axial field of view of 21.6 cm). This 3D system consists of a 16-slice CT and a PET scanner with four rings of lutetium oxyorthosilicate detectors.

After a topogram acquisition (110 kVp, 25 mAs) used for patient positioning, a CT transmission scan [130 kVp, 25 mAs (ref.), pitch 0.95] was acquired. Subsequently, patients were injected with 300 MBq of ¹³NH₃ at rest. A 12-min rest imaging acquisition was started simultaneously with the start of the rest ¹³NH₃ infusion (3 ml ¹³NH_3, rate 0.4 ml/s followed with 17 ml NaCl and flushed with 20 ml NaCl at rate 2 ml/s). Pharmacologic stress was induced by an intravenous adenosine infusion (0.14 mg/kg/min for 6 min) immediately after acquisition of rest images. One minute after the start of the adenosine infusion, a 12-min stress imaging acquisition was started. Two minutes later, 400 MBq of ¹³NH₃ was administered (3 ml, rate 0.4 ml/s). Immediately after completion of stress imaging, a second CT transmission scan was performed [130 kVp, 25 mAs (ref.), pitch 0.95].

Static, dynamic, and 16-bin ECG-gated images were generated from the list mode data. The acquired emission data were reconstructed using 3D attenuation-weighted ordered subsets expectation maximization (OSEM3D) reconstruction with a 168 × 168 matrix, zoom 2, a Gaussian filter with a full-width at half-maximum of 5 mm, two iterations, and 21 subsets for gated and dynamic images and TrueX (OSEM3D with PSF) reconstruction with a 256 × 256 matrix, zoom 2, a Gaussian filter of 4 mm, four iterations, and eight subsets for static images. CT-based attenuation, scatter, decay, and random corrections were applied to the reconstructed images.

Total scan duration was 25 min: 12 min for rest and 10.5 min for stress scans, with 2.5 min delay between these two parts. From each of the acquisitions dynamic, static and gated images were reconstructed. Dynamic rest images were reconstructed from the part of the dataset that was acquired directly after the initiation of the first ¹³NH₃ injection, using 25 frames: 1 × 10, 12 × 5, 2 × 10, 7 × 30, 2 × 60, 1 × 180 s. MBF was subsequently computed by applying the Hutchins model to the dynamic images (Hutchins et al. 1990). For reconstruction of the gated and static rest images, the first 2.5 min of the rest acquisition data were skipped to allow for blood pool clearance and the subsequent 9.5 min of data were used. Gated images were used to assess left ventricular ejection fraction and regional wall motion abnormalities, while static images provide visualization of myocardial perfusion. The dynamic stress images were reconstructed from the part of the dataset that was acquired from 30 s before initiation of the second ¹³NH₃ injection (which took place at exactly 15 min after the beginning of each scan) and onwards, using 26 frames for stress: 1 × 30, 1 × 10, 12 × 5, 2 × 10, 7 × 30, 2 × 60, 1 × 180 s. For reconstruction of static and gated stress images, the last 7.5 min of the acquisition data were used.

A cardiac specific motion correction algorithm from Siemens Molecular Imaging was used to detect the motion of the myocardium between the dynamic frames automatically. The motion was detected by a rigid image registration. The frames were re-aligned using an automatic motion correction method, propagating backwards from the final frame, comprising registrations between consecutive frames, until the frames no longer contained data that could be reliably registered due to change in image appearance as the sequence evolves.

Residual activity correction was applied for dynamic and static images obtained from the stress scan to exclude the interference of residual ¹³NH₃ activity from the rest acquisition. Dynamic data sets were processed by subtraction of residual activity present in the first frame of the stress study (acquired directly before the stress ¹³NH₃ injection) from the time activity curves using a residual correction method that was integrated into the Syngo MBF software package (Siemens Healthcare, Knoxville, Tennessee, USA). To assess the effect of this correction method, stress MBF values with and without residual activity correction will be provided. Static images were corrected by subtracting the residual activity measured at an interval of 2 min before the stress ¹³NH₃ injection and corrected for decay and patient motion.

The quality of the registration between PET and CT was reviewed by experienced technologists and, in case of misalignment, corrected manually by means of 3D translations on the registration matrix before the final reconstruction process was started (Kan et al. 2016). MBFs were measured globally and for separate coronary artery territories and corresponding MFRs were calculated. Vital parameters were continuously monitored and rate-pressure products (RPP) calculated.

Statistics

Statistical analysis was performed using SPSS software (version 20.0.0; IBM SPSS, Chicago, Illinois, USA). Categorical variables are presented as frequencies with percentages and continuous variables as mean ± standard deviation. Follow-up duration was described with median and interquartile range to better understand the distribution. Normal distribution was tested by the Shapiro-Wilk test. Data was subsequently divided by age and sex. Since most data was not normally distributed, significance between flow before and after residual activity correction was tested with the Wilcoxon Signed Ranks Test, significance of difference by sex with the Mann-Whitney U test, and significance of correlation by age with the 2-tailed Spearman’s rho test.

Results

One thousand eight hundred forty-four patients were referred for ¹³NH₃ myocardial PET/CT. After exclusion due to known CAD (n = 599), abnormal/positive ¹³NH₃ PET/CT results (n = 879), coronary calcifications on CT scan (n = 1406), and/or incomplete or suboptimal scans (n = 48), 225 patients were found suitable to enter the study. 19 ¹³NH₃ PET/CTs of these patients yielded stress MBFs below 1.8 ml/g/min, and those were also excluded. This resulted in 206 eligible patients. The average age of the resulting study group was 62 ± 11.7 years and 63 (31%) of the included patients were male. Baseline characteristics are listed in Table 1. During a median follow-up of 18 months (interquartile range 9–27) no MACEs were recorded in this group.

Table 1

Patient characteristics

Baseline characteristics
Subjects	206
Male no	63 (31%)
Age, years	62 ± 12
BMI	27 ± 5
Follow-up, months^a	18 (IQR = 9–27)
Smoker	29 (14%)
Diabetes	33 (12%)
Positive family history	70 (34%)
Hypercholesterolemia	61 (30%)
Hypertension	91 (44%)
MACE	0 (0%)

Values are n, mean ± standard deviation, or n (%)

BMI Body Mass Index. MACE Major Adverse Cardiac Event

^amedian and interquartile range (IQR)

RPP, global rest MBFs, stress MBFs and resulting MFRs are listed in Table 2, further categorized by sex and shown as boxplots in Figs. 1 and 2. The corresponding complete dataset can be found in Additional file 1. The global rest MBF for all patients was 1.02 ± 0.22 ml/g/min and global stress MBF was 2.54 ± 0.41 ml/g/min which resulted in a global MFR of 2.58 ± 0.60. RPP was significantly higher in females compared to males in rest (9370 ± 2487 vs. 8149 ± 1490, p = 0.001) and stress (12,939 ± 2871 vs. 11,956 ± 2321, p = 0.001). Global rest and stress MBF were significantly higher in females compared to males as well, with a significantly lower global MFR in females (p = ≤ 0.012). A division by age is listed in Table 3 and scatter-plotted in Fig. 3.

Spearman’s rho test showed a minor but significant negative correlation of MBF in stress (r = − 0.139, p = 0.047) and MFR (r = − 0.165, p = 0.018) with age, while MBF in rest was not correlated with age. The effect of the residual activity correction is assessed in Table 4, by providing stress MBF with and without residual activity correction. The residual activity correction method significantly reduced the stress MBF values (p = < 0.001); a mean global MBF without residual activity correction was measured of 2.93 ± 0.44 ml/g/min with a calculated mean residual activity of 0.39 ± 0.13 ml/g/min, resulting in a mean global MBF with residual activity correction of 2.54 ± 0.41 ml/g/min.

Table 2

Mean Rate Pressure Product, Myocardial Blood Flow and Myocardial Flow Reserve with residual activity correction divided by sex

	Total (n = 206)	Male (n = 63)	Female (n = 143)	P-value (male/female)
RPP rest	8991 ± 2293^a	8149 ± 1490^a	9370 ± 2487^a	0.001
RPP stress	12,939 ± 2871^a	11,956 ± 2321	13,382 ± 2990^a	0.001
MBF rest (ml/g/min)	1.02 ± 0.22^a	0.90 ± 0.19	1.08 ± 0.22^a	< 0.001
MBF stress (ml/g/min)	2.54 ± 0.41	2.43 ± 0.35	2.59 ± 0.43	0.012
MFR (stress/rest ratio)	2.60 ± 0.61^a	2.81 ± 0.58^a	2.50 ± 0.60^a	< 0.001

Mean results ± standard deviation

MBF Myocardial Blood Flow, MFR Myocardial Flow Reserve, RPP Rate Pressure Product

^anot normally distributed by Shapiro-Wilk test. Significance tested by Mann-Whitney U

Fig. 1
MBF and MFR by sex. Boxplot with Tukey whiskers, dots are outliers. MBF = Myocardial Blood Flow, MFR = Myocardial Flow Reserve

Fig. 2
MBF and MFR divided by coronaries. Boxplot with Tukey whiskers, dots are outliers. MBF = Myocardial Blood Flow, MFR = Myocardial Flow Reserve. LAD = Left Anterior Descending, LCX = Left Circumflex, RCA = Right Coronary Artery

Table 3

Mean Myocardial Blood Flow and Myocardial Flow Reserve with residual activity correction divided by age categories

Subgroup (n)	MBF rest (ml/g/min)	MBF stress (ml/g/min)	MFR (stress/rest ratio)
Total (206)	1.02 ± 0.22^a	2.54 ± 0.41	2.60 ± 0.61^a
Age < 50 (30)	1.05 ± 0.23	2.68 ± 0.48	2.66 ± 0.67
Age 50–59 (45)	0.99 ± 0.21	2.57 ± 0.43	2.73 ± 0.69^a
Age 60–69 (73)	0.99 ± 0.22^a	2.53 ± 0.39	2.66 ± 0.54
Age ≥ 70 (58)	1.08 ± 0.23	2.46 ± 0.36	2.39 ± 0.56^a

Mean results ± standard deviation

MBF Myocardial Blood Flow, MFR Myocardial Flow Reserve

^anot normally distributed by Shapiro-Wilk test

Fig. 3
Scatter plot MBF stress/rest and MFR by age with linear regression analysis. Significant negative correlation of MBF in stress (r = − 0.139, p = 0.047) and MFR (r = − 0.165, p = 0.018) with age. MBF = Myocardial Blood Flow, MFR = Myocardial Flow Reserve

Table 4

Mean Myocardial Blood Flow before and after residual activity correction divided by territory

Territory	MBF stress before RAC (ml/g/min)	MBF stress after RAC (ml/g/min)	P-value
LAD	2.87 ± 0.45^a	2.47 ± 0.41^a	< 0.001
LCX	3.07 ± 0.45	2.69 ± 0.42	< 0.001
RCA	2.94 ± 0.47	2.55 ± 0.45	< 0.001
Global	2.93 ± 0.44	2.54 ± 0.41	< 0.001

Mean results ± standard deviation

MBF Myocardial Blood Flow, RAC Residual Activity Correction, LAD Left Anterior Descending, LCX Left Circumflex, RCA Right Coronary Artery

^anot normally distributed by Shapiro-Wilk test

Discussion

In this cohort study myocardial blood flow values were established for global rest and stress MBF and global MFR for time-efficient ¹³NH₃ myocardial PET/CT with residual activity correction in patients without a history of CAD from a regular cohort of cardiac (out) patients who showed no signs of ischemia on the performed ¹³NH₃ myocardial PET/CT and no coronary calcifications on CT. This resulted in a patient population with an excellent prognosis, since no major adverse cardiac events were recorded during follow-up.

An earlier review of Gould et al. summarized global values of rest MBF (0.79 ± 0.06 ml/g/min), stress MBF (2.66 ± 0.90 ml/g/min) and MFR (3.42 ± 1.02) of 859 normal controls who underwent a ¹³NH₃ myocardial perfusion PET/CT (Gould et al. 2013). In these studies, a more common protocol was used with a delay of between rest and stress scans, typically 30 to 60 min, which negates the overlap between rest and stress images. Our study differs from most by applying a time-efficient acquisition and image processing protocol, which corrects for this overlap with a residual activity correction algorithm.

The rest MBF in the present study was higher (1.02 ± 0.22 vs. 0.79 ± 0.06 ml/g/min) compared to the data summarized by Gould et al. (Gould et al. 2013). However, the mean rest MBFs differ between the 64 individual studies included in the review, with a lowest mean rest MBF of 0.57 ± 0.15 ml/g/min and the highest mean rest MBF of 1.09 ± 0.20 ml/g/min. A closer look at the publications in this review shows significant differences in used method, software and hardware, which could explain the found range of mean rest MBF. While our rest MBF is on the higher end, it’s still within this range. The difference could not be explained by our time-efficient protocol, since rest MBF is not influenced by this method.

Residual activity had a significant effect on all stress MBFs, globally as well as in the separate territories, with a calculated global mean residual activity of 0.39 ± 0.13 ml/g/min. Notably, even though a time-efficient protocol was used with overlap, resulting in residual activity during the stress scans, the corrected stress MBF was similar compared to the data summarized by Gould et al. (2.54 ± 0.41 vs. 2.66 ± 0.90 ml/g/min). This resulted in lower MFR (2.60 ± 0.61 vs. 3.42 ± 1.02 ml/g/min, Tables 2 and 3) (Gould et al. 2013). A higher global rest and stress MBF with lower MFR was found in female patients. One explanation could be that female patients are more susceptible to mental stress before procedure (Marques et al. 2016), which would explain the increased RPP compared to males, resulting in increased MBF. Age had a small but significant negative correlation with global stress MBF and MFR, but previous studies have been contradictory on this matter (Bernacki et al. 2016; Czernin et al. 1993). The decline in the present study may be explained by a progression of coronary microvascular disease with age (Marinescu et al. 2015), by an increase of risk factors by age, or by currently unknown factors.

An alternative method to determine reference values could be obtained by performing ¹³NH₃ myocardial PET/CT scans with a time-efficient protocol on healthy patients with no risk factors. However, since in these low risk patients no additional testing or coronary computed tomography angiography is preferred to stress imaging (Task Force Members et al. 2013), these patients would not be representative to the average cardiac (outpatient) clinic population.

Our study adds to existing literature by establishing myocardial blood flow values on ¹³NH₃ myocardial PET/CT scans using a time-efficient protocol of patients with no sign of CAD, offering stress MBF values which agree with known reference values in normal studies without a time-efficient protocol. In addition, to our knowledge this is the first study to present the effects of temporal overlap and the subsequent obligatory residual activity correction method in a large number of patients. The time-efficient acquisition protocol allows for shorter test duration, since rest and stress components are performed in short order without having to reposition the patient. The data sets in this study were processed by the Syngo MBF software package. While comparison studies between different software packages are limited, a recent study demonstrates a moderate to good agreement in myocardial perfusion quantification between Syngo MBF and other software packages (Nesterov et al. 2017).

Residual activity correction is a relatively novel technique. To our knowledge, the application of ¹³NH₃ myocardial PET/CT scans using a time-efficient protocol with residual activity correction has been described in only two small studies. One study compares difference in MBF with and without residual activity correction of the same measurements, which were significant in the LAD and RCA territory, and concludes that the overestimation of stress MBF can be avoided by applying residual activity correction (Markousis-Mavrogenis et al. 2017). The other study comprises a preliminary validation of residual activity correction in a pilot study comparing two rest-acquisitions in 31 subjects, one with temporal overlap and residual activity correction and one without temporal overlap, and confirms matching myocardial blood flow values and statistical distribution (Lazarenko et al. 2014). While these findings are interesting, little detail is provided, and the number of subjects is small. Further validation of the technique could be of value, for example by direct comparison to standard imaging without temporal overlap, or validation against catheterization results.

Conclusions

Establishment of myocardial flow values for ¹³NH₃ myocardial PET/CT with a time-efficient protocol using residual activity correction yielded a global rest MBF of 1.02 ± 0.22 ml/g/min global stress MBF of 2.54 ± 0.41 ml/g/min and a resulting global MFR of 2.60 ± 0.61 for patients without CAD. Female patients showed a significantly higher MBF in both rest and stress compared to men, and age had a small but significant negative correlation with average stress MBF and MFR. Residual activity correction had a distinct significant effect resulting in a difference in global mean stress MBF before and after correction of 0.39 ± 0.13 ml/g/min.

Residual activity correction provides a time-efficient protocol, which results in reliable MBF value measurements in line with previous literature. Future validation for this novel method should focus on a direct comparison to standard imaging without temporal overlap and to catheterization results.

Abbreviations

¹³NH₃ :: Nitrogen-13 ammonia

CAD:: Coronary artery disease

FFR:: Fractional flow reserve

MACE:: Major adverse cardiovascular event

MBF:: Myocardial blood flow

MFR:: Myocardial flow reserve

PET/CT:: Positron Emission Tomography/Computed Tomography

RPP:: Rate pressure product

Declarations

Acknowledgements

The publication of this article was supported by funds of the European Association of Nuclear Medicine (EANM).

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Availability of data and materials

The dataset supporting the conclusions of this article is included within the article and its additional files.

Authors’ contributions

OTSJ: Analysing/interpretation of data, drafting manuscript. KRJJ: Acquisition and analysing of data, forming graphics, critically revising of manuscript. CJH: Critically revising of manuscript, general supervision. WM: Acquisition and analysing of data, critically revising of manuscript. vdZFM: Establishing aim of study, Acquisition and analysing of data, critically revising of manuscript. All authors read and approved the final manuscript.

Ethics approval and consent to participate

All patients gave written informed consent for the use of their data for scientific purposes. Besides the standard imaging protocol and clinical management no additional measurements or actions affecting the patient were performed. Therefore, approval of the local ethical committee for the present study was not necessary since the study does not fall within the scope of the Dutch Medical Research Involving Human Subjects Act (section 1.b WMO, 26th February 1998).

Consent for publication

Not applicable.

Competing interests

T. Opstal, dr. R.J.J. Knol, dr. J.H. Cornel, dr. M. Wondergem and dr. F.M. van der Zant have no conflicts of interest to disclose.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

(1)

Department of Nuclear Medicine, North West Clinics, Alkmaar, The Netherlands

(2)

Cardiac Imaging Division Alkmaar, North West Clinics, Alkmaar, The Netherlands

(3)

Department of Cardiology, North West Clinics, Alkmaar, The Netherlands

References

Anagnostopoulos C, Georgakopoulos A, Pianou N, Nekolla SG (2013) Assessment of myocardial perfusion and viability by positron emission tomography. Int J Cardiol 167(5):1737–1749View ArticlePubMedGoogle Scholar
Bernacki GM, Bahrainy S, Caldwell JH, Levy WC, Link JM, Stratton JR (2016) Assessment of the effects of age, gender, and exercise training on the cardiac sympathetic nervous system using positron emission tomography imaging. J Gerontol A Biol Sci Med Sci 71(9):1195–1201View ArticlePubMedPubMed CentralGoogle Scholar
Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J et al (1993) Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88(1):62–69View ArticlePubMedGoogle Scholar
Dorbala S, Di Carli MF (2014) Cardiac PET perfusion: prognosis, risk stratification, and clinical management. Semin Nucl Med 44(5):344–357View ArticlePubMedPubMed CentralGoogle Scholar
Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R et al (2013) Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol 62(18):1639–1653View ArticlePubMedGoogle Scholar
Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE (1990) Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 15(5):1032–1042View ArticlePubMedGoogle Scholar
Juarez-Orozco LE, Alexanderson E, Dierckx RA, Boersma HH, Hillege JL, Zeebregts CJ, et al (2016) Stress myocardial blood flow correlates with ventricular function and synchrony better than myocardial perfusion reserve: a nitrogen-13 ammonia PET study. J Nucl Cardiol. https://doi.org/10.1007/s12350-016-0669-y
Juneau D, Erthal F, Ohira H, Mc Ardle B, Hessian R, deKemp RA et al (2016) Clinical PET myocardial perfusion imaging and flow quantification. Cardiol Clin 34(1):69–85View ArticlePubMedGoogle Scholar
Kan H, Knol RJ, Lazarenko SV, Wondergem M, van der Zant FM (2016) Occurrence of typical perfusion defects attributed to jailed or occluded side branch after ramus descendens anterior stenting in a patient cohort referred for 13NH3 myocardial PET/CT. Nucl Med Commun 37(5):480–486View ArticlePubMedGoogle Scholar
Kawaguchi N, Okayama H, Kawamura G, Shigematsu T, Takahashi T, Kawada Y et al (2017) Clinical usefulness of coronary flow reserve ratio for the detection of significant coronary artery disease on (13)N-ammonia positron emission tomography. Circ JGoogle Scholar
Lazarenko SV, Knol RJ, Doodeman PA, Bruin VS, Pan XB, Declerck JM et al (2014) Validation of a fast 20 min two scans protocol for quantitative 13N-ammonia myocardial perfusion PET. Eur J Nucl Med Mol Imaging 41(Suppl 2):S169Google Scholar
Marinescu MA, Loffler AI, Ouellette M, Smith L, Kramer CM, Bourque JM (2015) Coronary microvascular dysfunction, microvascular angina, and treatment strategies. JACC Cardiovasc Imaging 8(2):210–220View ArticlePubMedPubMed CentralGoogle Scholar
Markousis-Mavrogenis G, Juarez-Orozco LE, Alexanderson E (2017) Residual activity correction in quantitative myocardial perfusion 13N-ammonia PET imaging: a study in post-MI patients. Hell J Cardiol 58:245View ArticleGoogle Scholar
Marques AA, Bevilaqua MC, da Fonseca AM, Nardi AE, Thuret S, Dias GP (2016) Gender differences in the neurobiology of anxiety: focus on adult hippocampal neurogenesis. Neural Plast 2016:5026713View ArticlePubMedPubMed CentralGoogle Scholar
Merhige ME, Breen WJ, Shelton V, Houston T, D'Arcy BJ, Perna AF (2007) Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. J Nucl Med 48(7):1069–1076View ArticlePubMedGoogle Scholar
Nesterov SV, Juárez-Orozco LE, Knol RJ, Sciagrà R, Slomka P, Alessio A et al (2017) AMMO-X: a cross-comparison study of ¹³N-ammonia PET MPQ software tools. Eur J Nucl Med Mol Imaging 44(Suppl 2):S299–S300Google Scholar
Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003View ArticleGoogle Scholar

European Journal of Hybrid Imaging

Myocardial blood flow and myocardial flow reserve values in 13N–ammonia myocardial perfusion PET/CT using a time-efficient protocol in patients without coronary artery disease

Abstract

Background

Results

Conclusions

Keywords

Background

Methods

Patient selection

Image acquisition and reconstruction parameters

Statistics

Results

Discussion

Conclusions

Abbreviations

Declarations

Acknowledgements

Funding

Availability of data and materials

Authors’ contributions

Ethics approval and consent to participate

Consent for publication

Competing interests

Publisher’s Note

Authors’ Affiliations

References

Copyright

Myocardial blood flow and myocardial flow reserve values in ¹³N–ammonia myocardial perfusion PET/CT using a time-efficient protocol in patients without coronary artery disease